Cargando…
An In Vitro and In Vivo Translational Research Approach for the Assessment of Sensitization Capacity and Residual Allergenicity of an Extensive Whey Hydrolysate for Cow’s Milk-Allergic Infants
Introduction: Hypoallergenic formulas prepared from hydrolyzed cow’s milk proteins are often used for the management of cow’s milk allergy (CMA) in infants. In this study, both in vitro assays and an in vivo mouse model for CMA were used to assess the sensitizing and allergenic potential of a newly...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320663/ https://www.ncbi.nlm.nih.gov/pubmed/35885248 http://dx.doi.org/10.3390/foods11142005 |
_version_ | 1784755846778978304 |
---|---|
author | Knipping, Karen Buelens, Laura Simons, Peter J. Garssen, Johan |
author_facet | Knipping, Karen Buelens, Laura Simons, Peter J. Garssen, Johan |
author_sort | Knipping, Karen |
collection | PubMed |
description | Introduction: Hypoallergenic formulas prepared from hydrolyzed cow’s milk proteins are often used for the management of cow’s milk allergy (CMA) in infants. In this study, both in vitro assays and an in vivo mouse model for CMA were used to assess the sensitizing and allergenic potential of a newly developed, extensive whey hydrolysate (eWH). Methods: Gel permeation chromatography was used to characterize the molecular weight distribution of the peptides. Residual antigenicity was measured using a beta-lactoglobulin ELISA as well as with immunoblotting using anti-beta-lactoglobulin (BLG) and anti-alpha-lactalbumin antibodies. In vitro residual allergenicity was assessed using huFcεRIα-RBL-2H3 cells sensitized with anti-bovine BLG human IgE. In vivo sensitizing and allergenic potential was assessed in a CMA mouse model by measuring the acute allergic skin response, anaphylactic shock score, body temperature, serum mMCP-1, whey-specific IgE, and cytokines. Results: There was no in vitro residual antigenicity and allergenicity observed of the eWH. Mice sensitized with eWH showed no acute allergic skin reaction after challenge with whey, confirmed by an absence of whey-specific IgE and anaphylactic symptoms and decrease in body temperature and mMCP-1 levels. Conclusions: Results from our in vitro and in vivo translational approach to assess sensitization capacity and residual allergenicity indicate that the newly developed eWH is safe for use in CMA infants. This was subsequently confirmed in a clinical study in which this eWH was tolerated by more than 90% (with 95% confidence) of infants or children with confirmed CMA. |
format | Online Article Text |
id | pubmed-9320663 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93206632022-07-27 An In Vitro and In Vivo Translational Research Approach for the Assessment of Sensitization Capacity and Residual Allergenicity of an Extensive Whey Hydrolysate for Cow’s Milk-Allergic Infants Knipping, Karen Buelens, Laura Simons, Peter J. Garssen, Johan Foods Article Introduction: Hypoallergenic formulas prepared from hydrolyzed cow’s milk proteins are often used for the management of cow’s milk allergy (CMA) in infants. In this study, both in vitro assays and an in vivo mouse model for CMA were used to assess the sensitizing and allergenic potential of a newly developed, extensive whey hydrolysate (eWH). Methods: Gel permeation chromatography was used to characterize the molecular weight distribution of the peptides. Residual antigenicity was measured using a beta-lactoglobulin ELISA as well as with immunoblotting using anti-beta-lactoglobulin (BLG) and anti-alpha-lactalbumin antibodies. In vitro residual allergenicity was assessed using huFcεRIα-RBL-2H3 cells sensitized with anti-bovine BLG human IgE. In vivo sensitizing and allergenic potential was assessed in a CMA mouse model by measuring the acute allergic skin response, anaphylactic shock score, body temperature, serum mMCP-1, whey-specific IgE, and cytokines. Results: There was no in vitro residual antigenicity and allergenicity observed of the eWH. Mice sensitized with eWH showed no acute allergic skin reaction after challenge with whey, confirmed by an absence of whey-specific IgE and anaphylactic symptoms and decrease in body temperature and mMCP-1 levels. Conclusions: Results from our in vitro and in vivo translational approach to assess sensitization capacity and residual allergenicity indicate that the newly developed eWH is safe for use in CMA infants. This was subsequently confirmed in a clinical study in which this eWH was tolerated by more than 90% (with 95% confidence) of infants or children with confirmed CMA. MDPI 2022-07-07 /pmc/articles/PMC9320663/ /pubmed/35885248 http://dx.doi.org/10.3390/foods11142005 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Knipping, Karen Buelens, Laura Simons, Peter J. Garssen, Johan An In Vitro and In Vivo Translational Research Approach for the Assessment of Sensitization Capacity and Residual Allergenicity of an Extensive Whey Hydrolysate for Cow’s Milk-Allergic Infants |
title | An In Vitro and In Vivo Translational Research Approach for the Assessment of Sensitization Capacity and Residual Allergenicity of an Extensive Whey Hydrolysate for Cow’s Milk-Allergic Infants |
title_full | An In Vitro and In Vivo Translational Research Approach for the Assessment of Sensitization Capacity and Residual Allergenicity of an Extensive Whey Hydrolysate for Cow’s Milk-Allergic Infants |
title_fullStr | An In Vitro and In Vivo Translational Research Approach for the Assessment of Sensitization Capacity and Residual Allergenicity of an Extensive Whey Hydrolysate for Cow’s Milk-Allergic Infants |
title_full_unstemmed | An In Vitro and In Vivo Translational Research Approach for the Assessment of Sensitization Capacity and Residual Allergenicity of an Extensive Whey Hydrolysate for Cow’s Milk-Allergic Infants |
title_short | An In Vitro and In Vivo Translational Research Approach for the Assessment of Sensitization Capacity and Residual Allergenicity of an Extensive Whey Hydrolysate for Cow’s Milk-Allergic Infants |
title_sort | in vitro and in vivo translational research approach for the assessment of sensitization capacity and residual allergenicity of an extensive whey hydrolysate for cow’s milk-allergic infants |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320663/ https://www.ncbi.nlm.nih.gov/pubmed/35885248 http://dx.doi.org/10.3390/foods11142005 |
work_keys_str_mv | AT knippingkaren aninvitroandinvivotranslationalresearchapproachfortheassessmentofsensitizationcapacityandresidualallergenicityofanextensivewheyhydrolysateforcowsmilkallergicinfants AT buelenslaura aninvitroandinvivotranslationalresearchapproachfortheassessmentofsensitizationcapacityandresidualallergenicityofanextensivewheyhydrolysateforcowsmilkallergicinfants AT simonspeterj aninvitroandinvivotranslationalresearchapproachfortheassessmentofsensitizationcapacityandresidualallergenicityofanextensivewheyhydrolysateforcowsmilkallergicinfants AT garssenjohan aninvitroandinvivotranslationalresearchapproachfortheassessmentofsensitizationcapacityandresidualallergenicityofanextensivewheyhydrolysateforcowsmilkallergicinfants AT knippingkaren invitroandinvivotranslationalresearchapproachfortheassessmentofsensitizationcapacityandresidualallergenicityofanextensivewheyhydrolysateforcowsmilkallergicinfants AT buelenslaura invitroandinvivotranslationalresearchapproachfortheassessmentofsensitizationcapacityandresidualallergenicityofanextensivewheyhydrolysateforcowsmilkallergicinfants AT simonspeterj invitroandinvivotranslationalresearchapproachfortheassessmentofsensitizationcapacityandresidualallergenicityofanextensivewheyhydrolysateforcowsmilkallergicinfants AT garssenjohan invitroandinvivotranslationalresearchapproachfortheassessmentofsensitizationcapacityandresidualallergenicityofanextensivewheyhydrolysateforcowsmilkallergicinfants |